ArticleOncogene2019

Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.

Varadha Balaji Venkadakrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.